216 related articles for article (PubMed ID: 23167687)
1. Occurrence, presentation and treatment of candidemia.
Mikulska M; Del Bono V; Ratto S; Viscoli C
Expert Rev Clin Immunol; 2012 Nov; 8(8):755-65. PubMed ID: 23167687
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology, risk factor, species distribution, antifungal resistance and outcome of Candidemia at a single French hospital: a 7-year study.
Tadec L; Talarmin JP; Gastinne T; Bretonnière C; Miegeville M; Le Pape P; Morio F
Mycoses; 2016 May; 59(5):296-303. PubMed ID: 26806101
[TBL] [Abstract][Full Text] [Related]
3. Candida infections in non-neutropenic children after the neonatal period.
Hacimustafaoglu M; Celebi S
Expert Rev Anti Infect Ther; 2011 Oct; 9(10):923-40. PubMed ID: 21973304
[TBL] [Abstract][Full Text] [Related]
4. Candida bloodstream infections: comparison of species distribution and resistance to echinocandin and azole antifungal agents in Intensive Care Unit (ICU) and non-ICU settings in the SENTRY Antimicrobial Surveillance Program (2008-2009).
Pfaller MA; Messer SA; Moet GJ; Jones RN; Castanheira M
Int J Antimicrob Agents; 2011 Jul; 38(1):65-9. PubMed ID: 21514797
[TBL] [Abstract][Full Text] [Related]
5. Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry.
Horn DL; Neofytos D; Anaissie EJ; Fishman JA; Steinbach WJ; Olyaei AJ; Marr KA; Pfaller MA; Chang CH; Webster KM
Clin Infect Dis; 2009 Jun; 48(12):1695-703. PubMed ID: 19441981
[TBL] [Abstract][Full Text] [Related]
6. Recent exposure to caspofungin or fluconazole influences the epidemiology of candidemia: a prospective multicenter study involving 2,441 patients.
Lortholary O; Desnos-Ollivier M; Sitbon K; Fontanet A; Bretagne S; Dromer F;
Antimicrob Agents Chemother; 2011 Feb; 55(2):532-8. PubMed ID: 21078946
[TBL] [Abstract][Full Text] [Related]
7. Relationship of fluconazole prophylaxis with fungal microbiology in hospitalized intra-abdominal surgery patients: a descriptive cohort study.
Zilberberg M; Yu HT; Chaudhari P; Emons MF; Khandelwal N; Shorr AF
Crit Care; 2014 Oct; 18(5):590. PubMed ID: 25358521
[TBL] [Abstract][Full Text] [Related]
8. Treatment of invasive candidiasis: between guidelines and daily clinical practice.
Tagliaferri E; Menichetti F
Expert Rev Anti Infect Ther; 2015 Jun; 13(6):685-9. PubMed ID: 25818660
[TBL] [Abstract][Full Text] [Related]
9. Candidemia and invasive candidiasis in adults: A narrative review.
Antinori S; Milazzo L; Sollima S; Galli M; Corbellino M
Eur J Intern Med; 2016 Oct; 34():21-28. PubMed ID: 27394927
[TBL] [Abstract][Full Text] [Related]
10. Impact of therapeutic strategies on the prognosis of candidemia in the ICU.
Puig-Asensio M; Pemán J; Zaragoza R; Garnacho-Montero J; Martín-Mazuelos E; Cuenca-Estrella M; Almirante B; ; ; ;
Crit Care Med; 2014 Jun; 42(6):1423-32. PubMed ID: 24557426
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology and outcomes of candidemia in 3648 patients: data from the Prospective Antifungal Therapy (PATH Alliance®) registry, 2004-2008.
Pfaller M; Neofytos D; Diekema D; Azie N; Meier-Kriesche HU; Quan SP; Horn D
Diagn Microbiol Infect Dis; 2012 Dec; 74(4):323-31. PubMed ID: 23102556
[TBL] [Abstract][Full Text] [Related]
12. Candida norvegensis fungemia in a liver transplant recipient.
Sanclemente G; Marco F; Cervera C; Hoyo I; Colmenero J; Pitart C; Almela M; Navasa M; Moreno A
Rev Iberoam Micol; 2015; 32(2):115-7. PubMed ID: 24794213
[TBL] [Abstract][Full Text] [Related]
13. Changing epidemiology of non-albicans candidemia in Korea.
Ko JH; Jung DS; Lee JY; Kim HA; Ryu SY; Jung SI; Joo EJ; Cheon S; Kim YS; Kim SW; Cho SY; Kang CI; Chung DR; Lee NY; Peck KR
J Infect Chemother; 2019 May; 25(5):388-391. PubMed ID: 30482698
[TBL] [Abstract][Full Text] [Related]
14. Background changing patterns of neonatal fungal sepsis in a developing country.
Ballot DE; Bosman N; Nana T; Ramdin T; Cooper PA
J Trop Pediatr; 2013 Dec; 59(6):460-4. PubMed ID: 23803724
[TBL] [Abstract][Full Text] [Related]
15. Candidemia in nonneutropenic critically ill patients: risk factors for non-albicans Candida spp.
Playford EG; Marriott D; Nguyen Q; Chen S; Ellis D; Slavin M; Sorrell TC
Crit Care Med; 2008 Jul; 36(7):2034-9. PubMed ID: 18552700
[TBL] [Abstract][Full Text] [Related]
16. Initial antifungal strategy does not correlate with mortality in patients with candidemia.
Murri R; Scoppettuolo G; Ventura G; Fabbiani M; Giovannenze F; Taccari F; Milozzi E; Posteraro B; Sanguinetti M; Cauda R; Fantoni M
Eur J Clin Microbiol Infect Dis; 2016 Feb; 35(2):187-93. PubMed ID: 26634352
[TBL] [Abstract][Full Text] [Related]
17. Our 2014 approach to candidaemia.
Koehler P; Tacke D; Cornely OA
Mycoses; 2014 Oct; 57(10):581-3. PubMed ID: 24863378
[TBL] [Abstract][Full Text] [Related]
18. Initial use of echinocandins does not negatively influence outcome in Candida parapsilosis bloodstream infection: a propensity score analysis.
Fernández-Ruiz M; Aguado JM; Almirante B; Lora-Pablos D; Padilla B; Puig-Asensio M; Montejo M; García-Rodríguez J; Pemán J; Ruiz Pérez de Pipaón M; Cuenca-Estrella M; ; ;
Clin Infect Dis; 2014 May; 58(10):1413-21. PubMed ID: 24642553
[TBL] [Abstract][Full Text] [Related]
19. Candida albicans versus non-albicans bloodstream infections: the comparison of risk factors and outcome.
Chi HW; Yang YS; Shang ST; Chen KH; Yeh KM; Chang FY; Lin JC
J Microbiol Immunol Infect; 2011 Oct; 44(5):369-75. PubMed ID: 21524971
[TBL] [Abstract][Full Text] [Related]
20. Candidemia in children.
Zaoutis T
Curr Med Res Opin; 2010 Jul; 26(7):1761-8. PubMed ID: 20513207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]